Table 3. Percentage seronegative samples (< 4 IU/ml) in children (2–14 years old) and young adults (15–39 years old) by gender in ESEN2 countries, 1996–2003.
| Country or area | Age group 2–14 years (%) |
Age group 15–39 years (%) |
||||||
|---|---|---|---|---|---|---|---|---|
| Overalla | 2–4 years | 5–9 years | 10–14 years | Overalla | Males | Females | ||
| Romania | 57.1 (1485) | 82.2 | 62.6 | 36.7 | 7.1 (1418) | 7.7 | 6.7 | |
| Group I | ||||||||
| Australiab | 4.6 (1594) | 5.0 | 4.5 | 4.5 | 9.3 (2011) | 16.0 | 2.7 | |
| Czech Republic | 0.9 (1178) | 0.0 | 0.9 | 1.4 | 6.4 (1302) | 11.6 | 1.1 | |
| Hungary | 2.2 (1313) | 2.0 | 2.2 | 2.4 | 4.8 (1300) | 4.4 | 5.3 | |
| Slovakia | 2.9 (1421) | 3.2 | 3.3 | 2.3 | 3.3 (1412) | 5.4 | 1.1 | |
| Slovenia | 3.7 (1312) | 7.1 | 1.6 | 3.8 | 2.4 (1300) | 3.9 | 1.3 | |
| Group II | ||||||||
| Cyprus | 8.7 (1307) | 13.3 | 7.7 | 6.5 | 6.1 (1286) | 5.8 | 6.3 | |
| Israel | 6.8 (1217) | 7.6 | 4.5 | 8.6 | 10.8 (1393) | 17.8 | 1.5 | |
| Latvia | 8.7 (1091) | 8.3 | 5.3 | 12.3 | 9.7 (1232) | 13.1 | 6.5 | |
| Lithuania | 5.6 (1213) | 3.6 | 3.9 | 8.1 | 5.1 (1373) | 5.3 | 5.0 | |
| Luxembourgc | 5.2 (994) | – | 5.2 | 5.5 | 6.9 (1123) | 7.7 | 6.2 | |
| Malta | 6.8 (570) | 9.6 | 6.3 | 6.2 | 4.4 (665) | 5.2 | 3.8 | |
| Swedend | 8.8 (604) | – | – | – | 2.6 (306) | 6.3 | 0.0 | |
| Group III | ||||||||
| Belgium | 12.8 (1219) | 11.0 | 13.2 | 8.5 | 5.8 (1457) | 7.7 | 3.8 | |
| Bulgaria | 28.4 (619) | 28.9 | 28.8 | 27.8 | 11.3 (799) | 10.5 | 11.8 | |
| England and Wales | 15.7 (1184) | 24.0 | 14.4 | 12.7 | 8.4 (1650) | 10.9 | 6.0 | |
| Ireland | 12.9 (805) | 15.5 | 13.8 | 10.2 | 5.6 (1212) | 9.2 | 3.6 | |
ESEN2, European Sero-Epidemiology Network 2. a n presented in parentheses. b Sera collected up to the age of 34 years old. c Sample size in 2–4 years age group was too small. d Sera collected from select ages.